| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 7e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |